X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Fermenta Biotech Ltd.
BSE CODE: 506414   |   NSE CODE: NA   |   ISIN CODE : INE225B01021   |   21-Nov-2024 Hrs IST
BSE NSE
Rs. 326.85
-4.35 ( -1.31% )
 
Prev Close ( Rs.)
331.20
Open ( Rs.)
324.00
 
High ( Rs.)
335.00
Low ( Rs.)
322.05
 
Volume
16257
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)-6.49  -19.75  10.48  18.01  22.07  
   CEPS(Rs)1.72  -11.27  18.69  24.61  27.25  
   DPS(Rs)1.25  1.25  1.25  2.50  5.00  
   Book NAV/Share(Rs)104.42  111.86  132.17  124.26  106.26  
   Tax Rate(%)-306.79  1.68  28.96  17.81  -33.91  
Margin Ratios          
   Core EBITDA Margin(%)12.16  11.85  19.77  25.38  22.82  
   EBIT Margin(%)4.17  -11.13  15.64  22.08  22.57  
   Pre Tax Margin(%)-1.50  -17.63  10.97  16.96  15.82  
   PAT Margin (%)-6.10  -17.33  7.79  13.94  21.19  
   Cash Profit Margin (%)1.61  -9.89  13.90  19.04  26.16  
Performance Ratios          
   ROA(%)-3.02  -7.98  4.08  8.05  11.54  
   ROE(%)-6.00  -16.19  8.18  15.63  23.36  
   ROCE(%)2.56  -6.18  9.85  14.54  13.83  
   Asset Turnover(x)0.50  0.46  0.52  0.58  0.54  
   Sales/Fixed Asset(x)0.88  1.07  1.28  1.56  2.07  
   Working Capital/Sales(x)3.97  8.08  3.02  3.24  3.10  
Efficiency Ratios          
   Fixed Capital/Sales(x)1.13  0.93  0.78  0.64  0.48  
   Receivable days85.90  102.78  100.64  84.96  86.87  
   Inventory Days111.94  132.79  123.42  120.58  122.20  
   Payable days181.65  140.63  115.51  137.08  200.03  
Valuation Parameters          
   PER(x)0.00  0.00  19.62  13.89  9.64  
   PCE(x)88.27  -9.49  11.01  10.17  7.81  
   Price/Book(x)1.45  0.96  1.56  2.01  2.00  
   Yield(%)0.83  1.17  0.61  1.00  2.35  
   EV/Net Sales(x)1.67  1.43  2.06  2.44  2.67  
   EV/Core EBITDA(x)11.27  9.91  9.47  8.98  9.69  
   EV/EBIT(x)40.09  -12.84  13.17  11.05  11.82  
   EV/CE(x)1.15  0.85  1.05  1.27  1.40  
   M Cap / Sales1.42  0.94  1.53  1.94  2.04  
Growth Ratio          
   Net Sales Growth(%)-6.64  -15.22  4.06  24.06  -25.74  
   Core EBITDA Growth(%)-4.14  -43.74  -16.79  22.48  -46.36  
   EBIT Growth(%)134.93  -160.36  -26.30  21.40  -52.38  
   PAT Growth(%)67.12  -288.52  -41.82  -18.38  -42.30  
   EPS Growth(%)67.14  -288.45  -41.82  -18.38  -81.65  
Financial Stability Ratios          
   Total Debt/Equity(x)0.44  0.67  0.62  0.64  0.72  
   Current Ratio(x)1.43  1.17  1.62  1.54  1.52  
   Quick Ratio(x)0.99  0.70  1.00  0.92  0.91  
   Interest Cover(x)0.74  -1.72  3.35  4.31  3.35  
   Total Debt/Mcap(x)0.30  0.69  0.39  0.31  0.35